Cargando…
ID4 Promotes Breast Cancer Chemotherapy Resistance via CBF1-MRP1 Pathway
Chemo-resistance is considered a key problem in triple negative breast cancer (TNBC) chemotherapy and as such, an urgent need exists to identify its exact mechanisms. Inhibitor of DNA binding factor 4 (ID4) was reported to play diverse roles in different breast cancer molecular phenotypes. In additi...
Autores principales: | Zhang, Xi, Gu, Guangyan, Song, Lin, Wang, Dan, Xu, Yali, Yang, Shuping, Xu, Bin, Cao, Zhixin, Liu, Chunmei, Zhao, Chunming, Zong, Yuanyuan, Qin, Yejun, Xu, Jiawen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171490/ https://www.ncbi.nlm.nih.gov/pubmed/32328189 http://dx.doi.org/10.7150/jca.31988 |
Ejemplares similares
-
SULT1E1 inhibits cell proliferation and invasion by activating PPARγ in breast cancer
por: Xu, Yali, et al.
Publicado: (2018) -
Cytotoxicity and reversal effect of sertraline, fluoxetine, and citalopram on MRP1- and MRP7-mediated MDR
por: Bin Kanner, Yuval, et al.
Publicado: (2023) -
Comparison of CBF1, CBF2, CBF3 and CBF4 expression in some grapevine cultivars and species under cold stress
por: Karimi, Maryam, et al.
Publicado: (2015) -
Involvement of human and canine MRP1 and MRP4 in benzylpenicillin transport
por: Zhao, Xiaofen, et al.
Publicado: (2019) -
MRP1 but Not MDR1 Is Associated with Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
por: Taheri, Mohsen, et al.
Publicado: (2013)